Zymeworks (ZYME) Change in Accured Expenses (2021 - 2026)

Zymeworks (ZYME) has 6 years of Change in Accured Expenses data on file, last reported at -$7.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 63.48% year-over-year to -$7.8 million; the trailing twelve-month figure through Mar 2026 stood at -$10.2 million (down 10.93% YoY), and the FY2025 full-year result was -$23.6 million, down 265.13% from the prior year.
• Change in Accured Expenses slipped to -$7.8 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $37.6 million in Q4 2022 to a low of -$28.3 million in Q1 2023.
• A 5-year average of -$2.1 million and a median of $1.3 million in 2025 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses jumped 551.75% in 2022 and sank 1031.47% in 2025, its largest moves.
• Tracing ZYME's Change in Accured Expenses over 5 years: stood at $37.6 million in 2022, then slumped by 159.42% to -$22.3 million in 2023, then soared by 132.87% to $7.3 million in 2024, then plunged by 81.8% to $1.3 million in 2025, then tumbled by 680.52% to -$7.8 million in 2026.
• Business Quant data shows ZYME's Change in Accured Expenses at -$7.8 million in Q1 2026, $1.3 million in Q4 2025, and $3.3 million in Q3 2025.